Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia: a literature review of pharmaceutical and clinical aspects

Article reviews formulation and pharmacokinetics of pegylated liposomal doxorubicin (PLD), dose, schedule contribution and concomitant drugs affecting palmar-plantar erythrodysesthesia (PPE), pathogenesis of PPE, and preventive measures and treatment of PLD-related PPE.

European Journal of Hospital Pharmacy